Hasnain Faheem Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
8
Insider Buys Sum
$7.51M
Insider Sells Quantity
8
Insider Sells Sum
$4.02M

Insider Activity of Hasnain Faheem

According to the SEC Form 4 filings, Hasnain Faheem, being in a position of

  1. director at Kura Oncology, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 10000 shares for $109,764,
    over all time since 2025-03-21, has bought 0 shares, and sold 32682 shares for $291,220.

Biography of Hasnain Faheem

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$109,7641100

Comparison of Insiders on Amount of Buys and Sells

2025-12-09SaleKura Oncology, Inc.
KURA
director
10,000
0.0118%
$10.98$109,764-10.12%
2025-03-21SaleKura Oncology, Inc.
KURA
director
22,682
0.0287%
$8.00$181,456+3.76%
2024-06-21PurchaseGossamer Bio, Inc.
GOSS
President & CEO
372,000
0.2168%
$0.67$250,282+48%
2024-03-27SaleGossamer Bio, Inc.
GOSS
President & CEO
23,172
0.0101%
$1.16$26,773-22.01%
2022-07-15PurchaseGossamer Bio, Inc.
GOSS
President & CEO
138,696
0.099%
$7.21$999,998-79.92%
2022-03-23SaleGossamer Bio, Inc.
GOSS
President & CEO
19,035
0.0254%
$8.91$169,697-4.09%
2020-10-14PurchaseGossamer Bio, Inc.
GOSS
director
193,040
0.3131%
$10.36$2M-1.02%
2019-09-27PurchaseGossamer Bio, Inc.
GOSS
director
20,000
0.0161%
$8.40$167,980-20.65%
2018-09-13SaleImmunic, Inc.
IMUX
director
177,443
0.368%
$0.44$77,679-41.16%
2017-09-14PurchaseImmunic, Inc.
IMUX
director
118,400
0.2764%
$4.19$495,741+36.47%
2016-08-12PurchaseImmunic, Inc.
IMUX
director
236,486
0.717%
$5.92$1.4M-26.26%
2008-07-09SaleBiogen Inc.
BIIB
EVP, Oncology/Rheumatology SBU
36,837
0.0129%
$62.07$2.29M-19.57%
2008-04-08SaleBiogen Inc.
BIIB
EVP, Oncology/Rheumatology SBU
6,425
0.0022%
$64.68$415,582-22.7%
2007-05-23SaleBiogen Inc.
BIIB
EVP, Oncology/Rheumatology SBU
7,446
0.0022%
$49.00$364,854+27.36%
2006-10-02SaleBiogen Inc.
BIIB
EVP, Oncology/Rheumatology SBU
11,244
0.0034%
$44.63$501,797+11.89%
Total: 15
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.